DeepMind's AlphaGenome 2 maps disease
Feedpost

DeepMind's AlphaGenome 2 maps disease

  • Google DeepMind launches AlphaGenome 2 to map cellular disease drivers
  • Model uses 100 million cell profiles to pinpoint gene-cell interactions
  • Researchers can use it to accelerate drug discovery and disease research
Summarized by AI ⓘ
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.